Study design questions ask what a study can measure. Case-control gives odds ratios; cohort gives relative risk.
Designs
- Randomized controlled trial: gold standard for treatment effect; randomization balances confounders; blinding reduces bias.
- Cohort: follows exposed and unexposed groups for outcomes; calculates incidence and relative risk; good for rare exposures.
- Case-control: starts with disease and compares exposures; calculates odds ratio; good for rare diseases; prone to recall bias.
- Cross-sectional: measures prevalence at one time; cannot show temporality.
- Case series and case report: descriptive only.
Meta-analysis
Pools data from multiple studies to increase power; heterogeneity and publication bias limit it.
Choosing
Rare disease: case-control. Rare exposure: cohort. Treatment efficacy: randomized trial. Prevalence: cross-sectional.
Keep going in biostatistics, epidemiology and ethics
- Bias, confounding and validity in research
- Relative risk, odds ratio, NNT and attributable risk
- Hypothesis testing: p-values, type I and II errors and power
- Normal distribution, standard deviation and standard error